Sotrovimab Treatment for COVID-19 Effective in a B-Cell-Depleted Patient After Anti-CD20 Treatment

Patients with hematologic malignancies are well known to have prolonged COVID-19 pneumonia. The cause has been reported to be B cell depletion after administration of anti-CD20 antibodies. Here, we report a case of COVID-19 pneumonia due to prolonged B-cell depletion after anti-CD20 antibody therapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Murase, Kazuyuki, Takada, Kohichi, Arihara, Yohei, Miyanishi, Koji, Kato, Junji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404336/
https://www.ncbi.nlm.nih.gov/pubmed/37551219
http://dx.doi.org/10.7759/cureus.41486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404336/
https://www.ncbi.nlm.nih.gov/pubmed/37551219
http://dx.doi.org/10.7759/cureus.41486

Ejemplares similares